Medtronic (NYSE: MDT) announced today that it appointed Kate Benedict as its new SVP and president of Acute Care & Monitoring (ACM).
In addition to the new role leading ACM, Benedict now serves on the company’s Medical Surgical portfolio leadership team.
“Kate is an inspirational and strategic leader with a proven track record of driving innovation and growth across the healthcare industry,” said Mike Marinaro, EVP and president of the Medical Surgical Portfolio at Medtronic. “Her people-first, patient-centric leadership style and deep experience across the industry make her uniquely suited to lead ACM as we revolutionize the future of healthcare to alleviate pain, restore health, and extend life.”
Benedict offers more than 25 years of experience in the healthcare sector. That includes medical devices, diagnostics, pharmaceuticals and drug delivery. The medtech giant said she’s known for delivering innovative solutions that drive above-market growth, strategic portfolio management and operational efficiency.
Before Medtronic, Benedict served as president of the global Health Solutions business at Flex. She also held executive roles at BD, Alcon, and Johnson & Johnson. Benedict began her career as an auditor at KPMG.
“I am honored to join Medtronic and lead an organization so deeply committed to patient safety and innovation,” said Benedict. “ACM’s vision to personalize patient care, anytime, anywhere motivates me, and I’m excited to support our teams in delivering world-class technology that empowers healthcare professionals and improves outcomes for patients around the world.”
More about the ACM business unit at Medtronic
Medtronic’s ACM unit has undergone some significant changes in recent years.
In February 2024, the company announced plans to exit what it labeled an increasingly unprofitable ventilator product line. That decision came more than a year after Medtronic said it would spin off its Patient Monitoring and Respiratory Interventions businesses, part of its Medical Surgical portfolio. Reports last year claimed that other medtech companies, including GE HealthCare and ICU Medical, plus private equity firm Carlyle Group were among those considering a purchase of the businesses.
Ultimately, Medtronic leadership elected to end the ventilator business. As a result, it combined what remained of Patient Monitoring and Respiratory Interventions into one business unit — ACM.
As part of this change, Bob White, the EVP and president of the Medical Surgical portfolio for Medtronic, also departed. Not long after White’s departure, Ariel Mactavish, president of the Respiratory Interventions unit, also left.
More recent updates for the ACM unit at Medtronic include an April agreement to distribute the Retia Medical Argos cardiac output monitor.
